AssureRx Health Promotes Wright To Lead Operations
AssureRx Health, Inc. announced that Donald R. Wright, Jr. has been promoted to Senior Vice President, Operations and Technology
AssureRx Health, Inc., a personalized medicine company specializing in pharmacogenetic products to help physicians select the right drug and right dose for psychiatric patients, announced that Donald R. Wright, Jr. has been promoted to Senior Vice President, Operations and Technology. His expanded responsibilities include managing the Company’s web-based software product development, overseeing information technology and molecular genetics laboratory operations, as well as customer support, field sales support, quality assurance, and human resources.Wright brings over 20 years of product development and operations expertise in management positions with Attachmate, Spotlight Solutions, ProfitLogic, and Domin-8 Enterprise Solutions. During his career, Don participated in over 25 successful product launches and played key leadership roles in planning and building early-stage entrepreneurial companies and market leading, international organizations. Don has served as CTO and founder of SaaS Capital, a finance company specializing in the SaaS software industry, as the CIO and vice president of products for Domin-8 Enterprise Solutions, as the CTO for Spotlight Solutions, a leading provider of retail pricing and revenue optimization software through its purchase by Oracle, and as global vice president of product development at Attachmate, where he led a 700 member software team and the creation and support of a $450 million software product line.
Commenting on the promotion, James S. Burns, President & CEO of AssureRx Health said, “Our goal is to provide pharmacogenetic and other clinical decision support products to help physicians individualize the treatment of patients with psychiatric disorders. Development and implementation of our first product, GeneSightRx®, came about through Don’s considerable leadership and experience. We now have the systems and infrastructure to support our clinical customers, as well as new products under development. Don will play an integral role in leading our future product offerings, operations, and Customer Service.”
GeneSight is a laboratory developed pharmacogenomic test that uses cutting edge technology to measure and analyze clinically important genomic variants in the treatment of psychiatric disorders. The results of the GeneSight report can help a clinician understand the way a patient’s unique genomic makeup may affect certain psychiatric drugs. The analysis is based on pharmacogenomics, the study of genomic factors that influence an individual’s response to drug treatments, FDA approved manufacturer’s drug labels, peer-reviewed scientific and clinical publications, and proven drug pharmacology. Quick turnaround time, combined with a customized report of the patient’s genomic makeup, clinical experience and other factors can help a physician make personalized drug treatment choices for each patient.
About AssureRx Health, Inc.
AssureRx Health, Inc. is a personalized medicine company that specializes in pharmacogenomics dedicated to helping physicians determine the right drug for individual patients suffering from neuropsychiatric and other disorders. The company was founded to commercialize industry-leading personalized medicine technology for neuropsychiatric disorders. Mayo Clinic and Cincinnati Children’s Hospital Medical Center are equity holders and technology collaborators.